References
- Xu XM, Zhou YQ, Luo GX, et al. The prevalence and spectrum of α and β thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol 2004;57:517–22
- Chui DH, Waye JS. Hydrops fetalis caused by α-thalassemia: an emerging health care problem. Blood 1998;91:2213–22
- Liao C, Wei J, Li Q, et al. Nonimmune hydrops fetalis diagnosed during the second half of pregnancy in Southern China. Fetal Diagn Ther 2007;22:302–5
- Liao C, Mo QH, Li J, et al. Carrier screening for α- and β-thalassemia in pregnancy: the results of an 11-year prospective program in Guangzhou Maternal and Neonatal hospital. Prenat Diagn 2005;25:163–71
- Tongsong T, Wanapirak C, Sirichotiyakul S, Chanprapaph P. Sonographic markers of hemoglobin Bart disease at midpregnancy. J Ultrasound Med 2004;23:49–55
- Tongsong T, Wanapirak C, Sirivatanapa P, et al. Prenatal eradication of Hb Bart's hydrops fetalis. J Reprod Med 2001;46:18–22
- Leung KY, Liao C, Li QM, et al. A new strategy for prenatal diagnosis of homozygous α(0)-thalassemia. Ultrasound Obstet Gynecol 2006;28:173–7
- Lam YH, Tang MH, Lee CP, Tse HY. Prenatal ultrasonographic prediction of homozygous type 1 alpha-thalassemia at 12 to 13 weeks of gestation. Am J Obstet Gynecol 1999;180:148–50
- Lam YH, Ghosh A, Tang MH, et al. Early ultrasound prediction of pregnancies affected by homozygous alpha-thalassaemia-1. Prenat Diagn 1997;17:327–32